Key points are not available for this paper at this time.
@RBC, as an intravenous living bacterial therapy for the selective initiation of tumor pyrolysis, provided a proof-of-concept of live bacteria vaccine potentiating tumor immune therapy.
Liu et al. (Wed,) studied this question.